Country Websites

Bringing Clarity to Complexity in the Intensive Care Unit

TherapyWise transforms kidney replacement therapy data into actionable insights that can help care teams identify trends, reduce burden, and drive continuous improvement across critical care settings.

In intensive care units (ICU), clinicians manage life-sustaining therapies amid constant alarms, interruptions, and fragmented data. Kidney replacement therapy (KRT) generates a continuous stream of clinical and operational data, much of it difficult to interpret in real time. Fresenius Medical Care (FME) developed TherapyWise with this reality in mind: not simply as another data tool, but as a way to bring clarity amidst the complexity of an ICU.

Seeing the bigger picture in kidney replacement therapy

Available through the NxView 4.0 platform for use with the NxStage® System One, TherapyWise is a cloud-based analytics capability that encourages ICU teams to look at data differently. It is designed to provide program-level insight into KRT delivered in acute and critical care settings by aggregating existing data across units and time to reveal patterns that might otherwise be difficult to detect.

In the ICU, those patterns matter. Variability in therapy delivery, frequent alarms, or workflow interruptions can impact both care consistency and staff burden. TherapyWise brings these specific parameters into sharper focus by consolidating data generated at the bedside and presenting it as longitudinal summaries. The result is a clearer, program-level view that supports more informed conversations about performance, efficiency, and quality improvement.

Turning complex data into actionable insight

At its core, TherapyWise presents treatment data as analytics, and analytics can help drive action. Through a centralized dashboard of key performance indicators, the platform highlights aggregated metrics such as treatment duration, average delivered versus average set dose, and trends in alarm frequency. This data helps teams track adherence to dosing targets, identify sources of alarm fatigue, and recognize variations in care delivery across different ICU settings.

The value of TherapyWise extends beyond visibility. By making data more accessible and meaningful, it helps hospital teams uncover opportunities to refine workflows, reduce interruptions, and support patient-safety initiatives. In doing so, it may help to address a critical challenge in intensive care: Improving program efficiency while reducing operational burden on clinicians.

Importantly, TherapyWise is designed to help the clinician understand trends over time, not for real-time decision-making. Its strength lies in allowing for retrospective analysis, which gives care teams the context they need to evaluate performance over time and identify opportunities for improvement.

Built on a secure, cloud-based infrastructure, TherapyWise exemplifies a broader shift toward data-driven care in Critical Care settings. By combining advanced analytics with FME’s expertise in KRT, this innovation offers ICU teams something both simple and powerful: A clearer perspective on how care is delivered and support for enhanced consistency and performance over time.

Learn more about TherapyWise here.